🧠 Let's start with some good news (November 2020): • TIB has won the second round of the EIT Health Headstart award. • TIB was selected to the second phase (investment readiness) by the Ship2B Foundation Health&Care program. • Time is Brain has obtained the “Seal of Excellence” from Horizon 2020’s SME Instrument call H2020-EIC-SMEInst-2018-2020. 🧠 After a stroke, time lost is brain lost 15 million people suffer stroke worldwide each year. It's the 3rd leading cause of death worldwide and the 1st cause of acquired disability. BraiN20 is a portable medical device that improves the diagnosis and prognosis after an Acute Ischemic Stroke (AIS). BraiN20 represents a change of the treatment guidelines for AIS thanks to its capacity to early diagnose the patients that will respond to Mechanical Thrombectomy (MT). BraiN20 optimizes the management for each AIS patient. BraiN20 reduces time to treatment for the patients suitable for MT, while it allows a correct reallocation of healthcare resources for those patients that will not respond to the treatment. Time is Brain's value is robust clinical evidence behind it: PROMISE clinical trial (gov: NCT04099615) (N=223). 🧠 BraiN20 benefits: • Better diagnosis -> reduction of time to MT -> better outcome • Decrease in disability • Improvement of the quality of life of AIS patient’s and their relatives 🧠 Contact information: • aliciamp@tibtimeisbrain.com